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SUMMARY. ‘JiangYaBiFeng’ (JYBF) tablet for treatment of hypertension in China is a composite pre-
scription of Chinese and western medicines. By using ultra high performance liquid chromatography cou-
pled with mass spectrometry (UPLC-MS), twenty-five compounds were simultaneously identified or tenta-
tively characterized based on their retention times and MS spectra. Nine target compounds, hy-
drochlorothiazide (HC), rutin, genistin, sophoricoside, baicalin, wogonoside, genistein, baicalein and
wogonin, were further quantified by ultra high performance liquid chromatography with diode-array de-
tector (UPLC-DAD). Chromatographic separation was successfully performed on a C18 column with gra-
dient elution of 0.1 % formic acid aqueous solution and acetonitrile at the flow rate of 0.4 mL/min in 15
min at 52 °C. Different wavelengths were used to determine corresponding compounds to ensure the best
resolution. According to the methodological validation, including linearity, precision, accuracy and stabili-
ty, this method was proved to be rapid, comprehensive, sensitive and feasible in the quality assessment of
JYBF tablet. 
